Jamie Greene focuses her practice on intellectual property issues involving biological and chemical technologies. Ms. Greene conducts domestic and foreign biological and chemical patent prosecution, particularly in the areas of biotechnology, diagnostics, isolation and purification methodology, immunology and pharmaceuticals. She renders patentability, patent validity and freedom-to-operate opinions, performs intellectual property due diligence; and provides advice to clients regarding various aspects of intellectual property including inventorship determinations, licensing, transactions, pre-litigation and litigation strategies. Ms. Greene has provided intellectual property advice and services to universities, large corporations, small start-up companies and government entities and has been awarded federal and state contracts for patent legal services. Ms. Greene is the Co-Chair of the firm's Health and Life Sciences team.

Ms. Greene has been a registered U.S. Patent Attorney since 1986. Prior to joining the firm, she served as in-house patent counsel for a pharmaceutical company. She has conducted enzyme isolation and characterization research at Sloan-Kettering Institute for Cancer Research and cardiac and allergy drug dispositon/metabolism research at Boehringer Ingelheim Ltd. Ms. Greene also performed graduate research in neuroimmunology and virology (HIV research conducted at the Centers for Disease Control and Prevention). She has been an adjunct professor of Intellectual Property Law at Emory University.

Ms. Greene was listed in The Best Lawyers of America^® for Biotechnology and Intellectual Property in 2010 and each of the ten years immediately preceding. She has been recognized as a 2009 Georgia "Super Lawyer" in the area of Intellectual Property by SuperLawyers magazine and is AV^® rated by Martindale-Hubbell*

*CV, BV, and AV are registered certification marks of Reed Elsevier Properties Inc., used in accordance with the Martindale-Hubbell certification procedure's standards and policies.